Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up

Improving naming treatment for people with aphasia after stroke

Official title: Integrating Complementary Learning Principles in Aphasia Rehabilitation Via Adaptive Modeling (Sub-study 1: Balancing Effortful and Errorless Learning Via Adaptive Naming Deadlines)

Run by University of Pittsburgh · NCT05653440 · Data updated 2026-11-12

This study tests new ways to help people with aphasia after a stroke improve their naming skills and use them in daily life.

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment30 (estimated)
SponsorUniversity of Pittsburgh
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedNovember 27, 2023
Main results expectedJanuary 31, 2027
Study endsJanuary 31, 2028
Registry record updatedApril 13, 2026
Trial IDNCT05653440 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals diagnosed with chronic aphasia due to a left hemisphere stroke, at least six months post-onset.

Probably not a fit

Patients with right hemisphere strokes or significant language comprehension impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates new treatment approaches for individuals with aphasia, focusing on improving long-term retention and everyday use of naming abilities. It involves a randomized within-subjects crossover design with 30 participants who will undergo 8 treatment sessions across three different conditions. The conditions include accuracy-maximized, effort-maximized, and effort-accuracy balanced approaches, with assessments conducted at various intervals to measure progress. The study aims to enhance the effectiveness of picture-based naming treatments by balancing effortful and errorless learning.

Why it matters

Potential benefit: If successful, this treatment could significantly improve the ability of patients with aphasia to recall and use words in daily life.

How similar studies have gone: While there have been studies on naming treatments for aphasia, this specific approach of balancing effort and errorless learning is novel and has not been extensively tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Existing diagnosis of chronic (\>6 months) aphasia subsequent to left hemisphere ischemic or hemorrhagic stroke.
* Impaired performance on 2/8 sections of the Comprehensive Aphasia Test.

Exclusion Criteria:

* History of other acquired or progressive neurological disease.
* Significant language comprehension impairments
* Unmanaged drug / alcohol dependence.
* Severe diagnosed mood or behavioral disorders that require specialize mental health interventions.

Where it's running

  • Language Rehab and Cognition Lab, Department of Communication Sciences and Disorders, School of Health and Rehabilitation Sciences, University of Pittsburgh
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: William Evans, PhD — University of Pittsburgh
  • Study coordinator: Alyssa Kelly, M.A., CCC-SLP
  • Email: ank155@pitt.edu
  • Phone: 412-648-3274

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Tailoring rTMS for Post-Stroke Aphasia Based on Language Profile

    A non-drug brain stimulation approach is tested to see if customizing rTMS targets improves language recovery in people with aphasia after a left-brain stroke.

    Recruiting University of South Carolina · Columbia, South Carolina · NCT07608588

  • tDCS in Rehab for Stroke-Related Aphasia: A Practical Implementation

    This study tests whether a 20-minute anodal tDCS session paired with speech therapy can be integrated into routine inpatient and outpatient rehab for people who recently had a stroke and now have aphasia.

    Recruiting Casa Colina Hospital and Centers for Healthcare · Pomona, California · NCT07535788

  • Decoding Mandarin speech features from brain-surface signals

    This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.

    Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07460037

  • Digital speech-therapy app Zenicom for subacute post-stroke aphasia in Korean speakers

    This trial will try the Zenicom digital speech-therapy app alongside conventional therapy to see if it helps Korean adults with aphasia after a recent (within 3 months) stroke.

    Recruiting at 3 sites Phase 2 Seoul National University Bundang Hospital · Seongnam-si and 2 other locations · NCT07397923

  • Deep phenotyping to explore recovery in young adults after stroke

    This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.

    Recruiting The Florey Institute of Neuroscience and Mental Health · Heidelberg, Victoria and 1 other locations · NCT07019493

  • TMS plus language therapy to improve word-finding after left-hemisphere stroke

    Researchers will try excitatory transcranial magnetic stimulation combined with semantic feature analysis language therapy to improve word-finding in adults with aphasia after left-hemisphere stroke.

    Recruiting Medical College of Wisconsin · Milwaukee, Wisconsin · NCT06974279

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.